Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Zheng, Ming
    Yang, Haiwei
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Sun, Li
    Guo, Miao
    Wang, Libin
    Tan, Ruoyun
    Wei, Ji-Fu
    Gu, Min
    CURRENT DRUG METABOLISM, 2019, 20 (07) : 609 - 618
  • [32] Long-Term Influence of CYP3A5, CYP3A4, ABCB1, and NR1I2 Polymorphisms on Tacrolimus Concentration in Chinese Renal Transplant Recipients
    Liu, Fei
    Ou, Yang-Meng
    Yu, Ai-Rong
    Xiong, Lei
    Xin, Hua-Wen
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2017, 21 (11) : 663 - 673
  • [33] The genetic polymorphisms of POR*28 and CYP3A5*3 significantly influence the pharmacokinetics of tacrolimus in Chinese renal transplant recipients
    Zhang, Jing-Jing
    Liu, Shuai-Bing
    Xue, Ling
    Ding, Xiao-Liang
    Zhang, Hua
    Miao, Li-Yan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 728 - 736
  • [34] CYP3A5 and MDR1 genetic polymorphisms and correlation with tacrolimus pharmacokenetics in Chinese liver transplant patients
    Li, Dan
    Zhu, Ji-Ye
    Gao, Jie
    Lou, Ya-Qing
    Zhang, Guo-Liang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 228 - 229
  • [35] CYP3A5 Polymorphism Effect on Cyclosporine Pharmacokinetics in Living Donor Renal Transplant Recipients: Analysis by Population Pharmacokinetics
    Song, Joohan
    Kim, Myeong Gyu
    Choi, Boyoon
    Han, Na Young
    Yun, Hwi-Yeol
    Yoon, Jeong-Hyun
    Oh, Jung Mi
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1141 - 1151
  • [36] Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects
    Zeng, Yong
    He, Yi-jing
    He, Fu-yuan
    Fan, Lan
    Zhou, Hong-hao
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (04) : 478 - 484
  • [37] Effect of bifendate on the pharmacokinetics of cyclosporine in relation to the CYP3A4*18B genotype in healthy subjects
    Yong Zeng
    Yi-jing He
    Fu-yuan He
    Lan Fan
    Hong-hao Zhou
    Acta Pharmacologica Sinica, 2009, 30 : 478 - 484
  • [38] Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
    Semiz, Sabina
    Dujic, Tanja
    Ostanek, Barbara
    Prnjavorac, Besim
    Bego, Tamer
    Malenica, Maja
    Mlinar, Barbara
    Marc, Janja
    Causevic, Adlija
    MEDICINSKI GLASNIK, 2011, 8 (01) : 84 - 89
  • [39] Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients
    Miura, Masatomo
    Satoh, Shigeru
    Kagaya, Hideaki
    Saito, Mitsuru
    Numakura, Kazuyuki
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    PHARMACOGENOMICS, 2011, 12 (07) : 977 - 984
  • [40] CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
    Kurzawski, Mateusz
    Dabrowska, Justyna
    Dziewanowski, Krzysztof
    Domanski, Leszek
    Peruzynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2014, 15 (02) : 179 - 188
12345